{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:51:01Z","timestamp":1740153061244,"version":"3.37.3"},"reference-count":18,"publisher":"The Journal of Rheumatology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:p>The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.<\/jats:p>","DOI":"10.3899\/jrheum.200480","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T16:17:15Z","timestamp":1592237835000},"page":"1584-1586","source":"Crossref","is-referenced-by-count":0,"title":["Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis"],"prefix":"10.3899","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-6697","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Leclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Bansback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Jarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"2022062017050724000_47.10.1584.1","doi-asserted-by":"crossref","first-page":"e0160753","DOI":"10.1371\/journal.pone.0160753","article-title":"Health-related quality of life (HRQOL) in idiopathic inflammatory myopathy: A systematic review","volume":"11","author":"Leclair","year":"2016","journal-title":"PLoS One"},{"key":"2022062017050724000_47.10.1584.2","doi-asserted-by":"crossref","first-page":"e0189840","DOI":"10.1371\/journal.pone.0189840","article-title":"A comparison of health-related quality of life (HRQOL) across four systemic autoimmune rheumatic diseases (SARDS)","volume":"12","author":"Greenfield","year":"2017","journal-title":"PLoS One"},{"key":"2022062017050724000_47.10.1584.3","first-page":"1024","article-title":"Nailfold videocapillaroscopy in idiopathic inflammatory myopathies","volume":"45","author":"Bangert","year":"2018","journal-title":"J Rheumatol"},{"key":"2022062017050724000_47.10.1584.4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"Suppl 61","key":"2022062017050724000_47.10.1584.5","first-page":"PA890","article-title":"Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality. European Respiratory Society International Congress, 2017; Milan, Italy","volume":"50","author":"Assayag","year":"2017","journal-title":"Eur Respir J"},{"key":"2022062017050724000_47.10.1584.6","unstructured":"McNamara S . Chronic myeloid leukemia. [Internet. Acessed May 21, 2020.] Available from: www.cmleukemia.com\/suzan-mc-namara-and-the-petition.html"},{"key":"2022062017050724000_47.10.1584.7","unstructured":"Leclair V Bernatsky S Hudson M . Myositis: an inclusive guide to the inflammatory myopathies. London: Jaypee Brothers; in press."},{"key":"2022062017050724000_47.10.1584.8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1750-1172-8-171","article-title":"The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases","volume":"8","author":"Rodger","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2022062017050724000_47.10.1584.9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12969-019-0326-5","article-title":"The PRINTO evidence-based proposal for glucocorticoids tapering\/discontinuation in new onset juvenile dermatomyositis patients","volume":"17","author":"Giancane","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"2022062017050724000_47.10.1584.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.23248"},{"key":"2022062017050724000_47.10.1584.11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second childhood arthritis and rheumatology research alliance consensus conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2022062017050724000_47.10.1584.12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrrheum.2013.140","article-title":"The landscape of comparative effectiveness research in rheumatology","volume":"10","author":"DeWitt","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2022062017050724000_47.10.1584.13","unstructured":"Weinfurt K . Living textbook of pragmatic clinical trials. [Internet. Accessed May 21, 2020.] Available from: rethinkingclinicaltrials.org\/chapters\/pragmatic-clinical-trial\/what-is-a-pragmatic-clinical-trial"},{"key":"2022062017050724000_47.10.1584.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211400"},{"key":"2022062017050724000_47.10.1584.15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.0000000000004061","article-title":"Physical activity monitoring: a promising outcome measure in idiopathic inflammatory myopathies","volume":"89","author":"Bachasson","year":"2017","journal-title":"Neurology"},{"issue":"Suppl 10","key":"2022062017050724000_47.10.1584.16","first-page":"2171","article-title":"Functional measures and patient home self-assessments in the idiopathic inflammatory myopathies","volume":"69","author":"Kocoloski","year":"2017","journal-title":"Arthritis Rheum"},{"key":"2022062017050724000_47.10.1584.17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s13063-015-1123-1","article-title":"Making smart investment decisions in clinical research","volume":"16","author":"Bansback","year":"2015","journal-title":"Trials"},{"key":"2022062017050724000_47.10.1584.18","doi-asserted-by":"crossref","first-page":"e0216075","DOI":"10.1371\/journal.pone.0216075","article-title":"Preventing rheumatoid arthritis: preferences for and predicted uptake of preventive treatments among high risk individuals","volume":"14","author":"Harrison","year":"2019","journal-title":"PLoS One"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.200480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:07:17Z","timestamp":1655770037000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.200480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,1]]}},"alternative-id":["10.3899\/jrheum.200480"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.200480","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"type":"print","value":"0315-162X"},{"type":"electronic","value":"1499-2752"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}